Thursday, April 19, 2012
Videos in Playlist:
Early Career Panel Discussion
Albert Phillip Owens III, Ph.D., University of North Carolina at Chapel Hill, Chapel Hill, N.C., Jordan D. Miller, Ph.D., Mayo Clinic, Rochester, Minn., and Daisy Sahoo, Ph.D., Medical College of Wisconsin, Milwaukee, Wis.
SVS and PVD, expanding involvement in ATVB
Alan Dardik, M.D., PH.D., and Mary McDermott, M.D.
ATVB 2012 Final Program & Abstracts
|Plenary Session III - Young Investigator Award Competition (8 a.m.)|
|Kenneth M. Brinkhous Young Investigator Prize in Thrombosis Competition|
|Protein Disulfide Isomerase Plays an Important Role in αMβ2 Integrin-Mediated Neutrophil Recruitment During Vascular Inflammation |
Jaehyung Cho, University of Illinois, Chicago, Ill.
|Protein Kinase C Regulation of 12-Lipoxygenase-Mediated Human Platelet Activation |
Michael Holinstat, Thomas Jefferson University, Philadelphia, Pa.
|Discoid Platelet Aggregations Visualized by in Vivo Molecular Imaging Without Endothelium Disruption and Contribution of Inflammatory Cytokine, Ros and Integrin Signaling |
Satoshi Nishimura, The University of Tokyo, Tokyo, Japan
|Monocyte Tissue Factor-Dependent Activation of Coagulation in Hypercholesterolemic Mice and Monkeys Is Inhibited by Simvastatin |
Albert Phillip Owens III, PhD, University of North Carolina at Chapel Hill, Chapel Hill, N.C.
|The Metalloprotease ADAMTS13 Reduces VWF-Mediated Vascular Inflammation and Early Development of Atherosclerosis in Mice|
Anil K. Chauhan, University of Iowa, Iowa
|Reactive Oxygen Species Mediate TLR4 MyD88 Independent Signaling in Human Hemoglobin-Associated Macrophages Through TLR4 Lipid Raft Interactions|
Aloke Finn, Emory University School of Medicine, Atlanta, Ga.
|Antiatherosclerotic Effects of miR-33 Inhibition: Increased Reverse Cholesterol Transport and Alternative-Activation (M2) of Macrophages|
Katey J. Rayner, New York University, New York, N.Y.
Presentation slides no longer available.
|Cholesteryl Ester Transfer Protein Interactions with Lipoproteins: Insights into Mechanisms by Electron Microscopy and Molecular Dynamics Simulation |
Gang Ren, Lawrence Berkeley National Lab, Berkeley, Calif.
|Concurrent Session III B - Mechanisms of Atherosclerosis, Platelet Production, Signaling and Function (10:30 a.m.)|
|Role of Platelets in Neovascularization |
Tatiana Byzova, Ph.D., FAHA, Cleveland Clinic, Cleveland, Ohio
|Plenary Session IV: Inflammasome Regulation of Metabolic Disease (1:30 p.m.)|
|Linking Lipid Metabolism and Innate Immunity via SREBP-1 |
Timothy Osborne, Ph.D., Stanford-Burnham Medical Research Institute, Orlando, Fla.
|Nanoparticle-Mediated siRNA Targeting of Macrophages in Cardiovascular Disease |
Matthias Nahrendorf, M.D., Ph.D., MGH Center for Systems Biology, Harvard Medical School, Boston, Mass.
- About every 25 seconds, an American will experience a coronary event, and every minute someone will die of one.
- This year, about 785,000 Americans will have a new coronary attack, and about 470,000 will have a recurrent attack.
- About 29 percednt of patients with MI are patients with STEMI.
- Average age at first MI is 64.5 years for men and 70.3 years for women.
- The estimated average number of years of life lost because of an MI is 16.6.
- Learn more in Heart Disease & Stroke Statistics: 2012 Update